QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 creative-medical-technologies-will-be-issued-us-patent-number-12391925-tomorrow-titled-prevention-andor-treatment-of-type-1-diabetes-by-augmentation-of-myeloid-suppressor-cell-activity

https://x.com/patentgrants/status/1957532080155562158?s=46&t=dtUiyC3dUs5yGRgT9qYHWg

 us-stocks-likely-to-open-lower-a-day-after-nasdaq-hits-record-high-nvidia-kellogg-klotho-in-focus

U.S. stock futures declined on Thursday after ending higher on Wednesday. Futures of major benchmark indices were trading lower.

 creative-medical-technology-has-received-a-notice-of-allowance-for-a-us-patent-titled-treatment-of-heart-failure-andor-post-infarct-pathological-remodeling-by-ex-vivo-reprogrammed-immune-cells

https://patentcenter.uspto.gov/applications/17559970/ifw/docs

 creative-medical-technology-announces-ovastem-shows-85-hormonal-improvement-70-success-orphan-drug-designation-filed

Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ), a leading biotechnology innovator in regenerative medicine, enthusias...

 creative-medical-technology-holdings-announces-mid-term-follow-up-study-data-reporting-reduction-in-opioid-use-by-chronic-lower-back-pain-patients-undergoing-stemspine-procedure-using-allostem

Notably, over 90% of patients reported no opioid use for pain management three years post-procedure, with an 80% persistent red...

 creative-medical-technology-reports-one-year-results-for-allostem-type-2-diabetes-program

Results demonstrate that CELZ-201 achieved an 80% overall efficacy rate in reducing insulin dependency and stabilizing hemoglob...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION